Literature DB >> 4006904

Integration of transfected LTR sequences into the c-raf proto-oncogene: activation by promoter insertion.

H Mölders, J Defesche, D Müller, T I Bonner, U R Rapp, R Müller.   

Abstract

A malignant cell line (clone S1) isolated after co-transfection of normal NIH3T3 DNA and Moloney leukemia virus long terminal repeat (Mo-LTR) sequences has previously been described to contain an activated c-raf oncogene. Here, we report the isolation by molecular cloning and the structural analysis of the LTR-activated c-raf gene. As shown by Southern blot and nucleotide sequence analyses, the transfected Mo-LTR sequences integrated into the 5th intron of the endogenous c-raf proto-oncogene. This intragenic LTR insertion led to the expression of high levels of LTR-U5-c-raf hybrid transcripts indicating an initiation of transcription from the Mo-LTR promoter. Transcriptional activation of c-raf is accompanied by the synthesis of large amounts of cytoplasmic c-raf protein. Immunoblot analysis suggests that the proteins encoded by the LTR-activated c-raf gene are truncated compared with the normal c-raf gene product(s). Our results indicate a promoter insertion mechanism of c-raf activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006904      PMCID: PMC554244          DOI: 10.1002/j.1460-2075.1985.tb03685.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas.

Authors:  G S Payne; J M Bishop; H E Varmus
Journal:  Nature       Date:  1982-01-21       Impact factor: 49.962

4.  Identification of a functional promoter in the long terminal repeat of Rous sarcoma virus.

Authors:  T Yamamoto; B de Crombrugghe; I Pastan
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.

Authors:  C Van Beveren; J G Goddard; A Berns; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

7.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes.

Authors:  R Müller; E F Wagner
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

8.  Transforming activity of DNA of chemically transformed and normal cells.

Authors:  G M Cooper; S Okenquist; L Silverman
Journal:  Nature       Date:  1980-04-03       Impact factor: 49.962

9.  Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus.

Authors:  B Levinson; G Khoury; G Vande Woude; P Gruss
Journal:  Nature       Date:  1982-02-18       Impact factor: 49.962

10.  Identification of a RNA polymerase II initiation site in the long terminal repeat of Moloney murine leukemia viral DNA.

Authors:  S A Fuhrman; C Van Beveren; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

View more
  30 in total

1.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 2.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

3.  B-raf, a new member of the raf family, is activated by DNA rearrangement.

Authors:  S Ikawa; M Fukui; Y Ueyama; N Tamaoki; T Yamamoto; K Toyoshima
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

4.  The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene.

Authors:  T I Bonner; H Oppermann; P Seeburg; S B Kerby; M A Gunnell; A C Young; U R Rapp
Journal:  Nucleic Acids Res       Date:  1986-01-24       Impact factor: 16.971

5.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis.

Authors:  V P Stanton; D W Nichols; A P Laudano; G M Cooper
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

6.  Induction of proliferation of neuroretina cells by long terminal repeat activation of the carboxy-terminal part of c-mil.

Authors:  C Dozier; F Denhez; J Coll; P Amouyel; B Quatannens; A Begue; D Stehelin; S Saule
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

7.  Activation of human c-raf-1 by replacing the N-terminal region with different sequences.

Authors:  T Tahira; M Ochiai; K Hayashi; M Nagao; T Sugimura
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

8.  Protein product of proto-oncogene c-mil.

Authors:  T Patschinsky; B Schroeer; K Bister
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

9.  Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human.

Authors:  K Huebner; A ar-Rushdi; C A Griffin; M Isobe; C Kozak; B S Emanuel; L Nagarajan; J L Cleveland; T I Bonner; M D Goldsborough
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Rat c-raf oncogene activation by a rearrangement that produces a fused protein.

Authors:  F Ishikawa; F Takaku; M Nagao; T Sugimura
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.